Life Sciences

The St. Louis area's focus on plants is an inherited trait of global proportions.

GE and partners establish a new stem-cell therapies center in Toronto.

A specialist pharmaceutical firm founded in Buffalo hits its stride as a multinational with major investments in the US and China.

Cross-disciplinary collaboration is in the DNA of America's crossroads.

A billion-dollar fund and a gigantic conglomerate drive biopharma investment in South Korea.

The latest UPS Healthcare Logistics Survey shows your company may need a targeted therapy to reduce its supply chain pain.

The latest investments in North Carolina are proof of life (sciences) beyond RTP.

A new HQ from AtriCure is just the latest addition to a robust cluster in Mason, Ohio.

Value chain analysis will sharpen your site selection strategy in Europe — and anywhere else.

Companies and institutions like to hold onto IP for all it's worth. But could they be squeezing the life out of innovation?

South Carolina’s Charleston region is building an 'incredible resource' for biomed companies.

The newest healthcare hubs from UPS show the logistics needs of life sciences firms can run hot and cold.

A brief visit to the fast-changing world of medical tourism.

Carrying signatures and hope from an entire state, the beams at the core of a new cancer center are raised in Omaha.

Three years after a significant bioscience project announcement, Georgia takes a giant step toward creating an industry hub.

Two announcements from one company show the power of university partnerships to further company and area competitiveness.

Cold-chain improvements are afoot on both sides of the Atlantic.

Novo Nordisk's 'Bright Sky' will help North Carolina continue to shine.

Yesterday it was 'Shark Tank,' today it's the world for a Florida-born manufacturer of synthetic humans.

A global consultancy issues two new reports on global biopharma competitiveness, finding the US tops and its northern neighbor wanting.

As MicroVention comes home to Aliso Viejo, its Japanese parent company feels increasingly at home in California.

Galapagos Evolves in France reports that a Paris-area life sciences hub moved fast to meet a Belgian biotech firm's needs.

Think RTP is aging? Bayer CropScience's investments indicate it's in the flower of youth.

Two years after its initial vision, DMC is now taking shape in MN.